Medicine and Dentistry
Rituximab
100%
Fc Receptor
100%
Autoimmunity
100%
Rheumatoid Arthritis
66%
B Cell
66%
Systemic Lupus Erythematosus
66%
Inflammatory Arthritis
66%
Natural Killer Cell
66%
Antibody Dependent Cellular Cytotoxicity
50%
Arthritis
16%
Ex Vivo
16%
Medical Research
16%
Flow Cytometry
16%
Allele
16%
Cohort Analysis
16%
Single Nucleotide Polymorphism
16%
Cell Antibody
16%
Gene Locus
16%
Receptor Expression
16%
CD20
16%
Immunoglobulin G1
16%
Homozygosity
16%
DAS28
16%
Multiplex Ligation Dependent Probe Amplification
16%
Copy Number Variation
16%
Lupus Erythematosus
16%
Diseases
16%
Immunology and Microbiology
Autoimmunity
100%
Fc Receptor
100%
Rituximab
100%
FCGR3A
100%
B Cell
57%
Systemic Lupus Erythematosus
57%
Inflammatory Arthritis
57%
Natural Killer Cell
57%
Antibody-Dependent Cell-Mediated Cytotoxicity
42%
Lupus Erythematosus
14%
Arthritis
14%
Single Nucleotide Polymorphism
14%
Gene Locus
14%
Cell Antibody
14%
Allele
14%
Immunoglobulin G1
14%
Homozygosity
14%
CD20
14%
Multiplex Ligation Dependent Probe Amplification
14%
Copy Number Variation
14%
Biochemistry, Genetics and Molecular Biology
Genetics
100%
FCGR3A
100%
Autoimmunity
100%
Fc Receptor
100%
Rituximab
100%
B Cell
57%
Natural Killer Cell
57%
Antibody Dependent Cellular Cytotoxicity
42%
Genotyping
28%
Single-Nucleotide Polymorphism
14%
Cohort Study
14%
Copy-Number Variation
14%
Homozygosity
14%
Allele
14%
Gene Locus
14%
Flow Cytometry
14%
Multiplex Ligation-Dependent Probe Amplification
14%
CD20
14%